Home » Stocks » ACUR

Acura Pharmaceuticals, Inc. (ACUR)

Stock Price: $0.3600 USD 0.0400 (12.50%)
Updated Feb 26, 2021 3:55 PM EST - Market closed
Market Cap 6.84M
Revenue (ttm) 4.07M
Net Income (ttm) -810,000
Shares Out 32.34M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $0.3600
Previous Close $0.3200
Change ($) 0.0400
Change (%) 12.50%
Day's Open 0.3751
Day's Range 0.3500 - 0.3751
Day's Volume 22,238
52-Week Range 0.12 - 0.45

News

There are no news available yet.

About ACUR

Acura Pharmaceuticals, a specialty pharmaceutical company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
1935
CEO
Robert Jones
Employees
12
Stock Exchange
OTCMKTS
Ticker Symbol
ACUR
Full Company Profile

Financial Performance

In 2019, ACUR's revenue was $2.66 million, an increase of 548.05% compared to the previous year's $410,000. Losses were -$3.77 million, -1.77% less than in 2018.

Financial Statements